Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01050569 · ClinicalTrials.gov registry record · Phase 2
Innovative Interventions for Smoking Cessation
A Phase 2 study of Tobacco Use Disorder, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 235
- Enrollment target
- 2
- Study locations
NCT01050569 is a Phase 2 study of Tobacco Use Disorder that has completed, run by University of Minnesota. The registered enrollment target is 235 participants, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The trial reports 2 study locations across 1 state.
The verdict
NCT01050569, a Phase 2 study of Tobacco Use Disorder, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 235 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only on abstinence, time to relapse and toxicant levels. The study will determine if adding nicotine replacement medication to the very low content cigarettes (VLNC) will augment treatment compared to nicotine patch only or to very low nicotine content cigarettes only.
Conditions Studied
Interventions
- DRUG Nicotine Patch
- OTHER VLNC Cigarette
- OTHER VLNC Cigarette Plus Nicotine Patch
Study Locations (2)
Minnesota
- University of Minnesota - Duluth
- University of MN's Tobacco Use Research Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01050569
The ClinicalTrials.gov registry entry for NCT01050569 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT01050569 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01050569 about?
NCT01050569 is a clinical study titled "Innovative Interventions for Smoking Cessation". The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only and very low nicotine content cigarette only on abstinence, time to relapse and toxicant levels. The study will deter...
What is the current status of trial NCT01050569?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 235 participants. The study started on 2008-10. Estimated completion is 2012-06.
What conditions does trial NCT01050569 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT01050569?
The interventions under investigation include: Nicotine Patch (DRUG), VLNC Cigarette (OTHER), VLNC Cigarette Plus Nicotine Patch (OTHER).
Who is sponsoring clinical trial NCT01050569?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01050569 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
RECRUITING · Phase 2
-
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.